The global race to understand COVID-19 variants
A new trial including the University of Melbourne is investigating who could remain susceptible to SARS-CoV-2 variants after COVID-19 infection or vaccination
From decades to days: 3D modelling tuberculosis
3D modelling of TB mutations means doctors could soon tailor individual treatments for the disease in days, not years, say University of Melbourne researchers.
Tuberculosis: Still a major killer
University of Melbourne researchers estimate for first time the burden of tuberculosis on adolescents and young adults, a group often ignored in disease control